The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies
Author:
Viengkhou Barney, Hayashida Emina, McGlasson Sarah, Emelianova Katie, Forbes Deborah, Wiseman Stewart, Wardlaw Joanna, Verdillo Rovin, Irani Sarosh R., Duffy Darragh, Piehl Fredrik, Loo Lipin, Pagenstecher Axel, Neely G. Greg, Crow Yanick J., Campbell Iain L., Hunt David P.J., Hofer Markus J.ORCID
Reference61 articles.
1. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1;Crow;Am. J. Med. Genet. A,2015 2. cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing;Uggenti;Nat. Genet.,2020 3. Treatments in Aicardi-Goutières syndrome;Crow;Dev. Med. Child Neurol.,2020 4. Detection of interferon alpha protein reveals differential levels and cellular sources in disease;Rodero;J. Exp. Med.,2017 5. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study;Rice;Lancet Neurol.,2013
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|